Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Development of a Novel DPI: Opportunities and Constraints

A case study in the development of a novel dry powder inhaler (DPI) that puts the patient at the centre of the design process.

By Guillaume Brouet and Christophe Fagot at Valois Pharma (December 2009)

Keywords: Novel DPI, dry poder Inhaler, therapy, Brouet, Fagot, Valois Pharma, In Vivo, In Vitro,

    View full article    |    Back to Ingredients, Formulations and Finishing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |